世界の長時間作用型注射薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Long-acting Injectable Medications Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4439
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、長時間作用型注射薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（第一世代、第二世代）、用途別市場規模（統合失調症、避妊、HIV、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・長時間作用型注射薬の市場動向
・企業の競争状況、市場シェア
・長時間作用型注射薬の種類別市場規模と予測2016-2027（第一世代、第二世代）
・長時間作用型注射薬の用途別市場規模と予測2016-2027（統合失調症、避妊、HIV、その他）
・長時間作用型注射薬の北米市場規模2016-2027（アメリカ、カナダ）
・長時間作用型注射薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・長時間作用型注射薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・長時間作用型注射薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・長時間作用型注射薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Eli Lilly、Alkermes、Johnson & Johnson、Zogenix、DURECT、Mapi Pharma、GSK、MedinCell、Oakwood Labs、Nanomi、Pharmathen、Kashiv BioSciences）
・結論

Long-acting injectables (LAIs) are unique tools used in psychiatric pharmacy to help improve patient outcomes. They offer a number of benefits compared to oral therapy, including confirmed patient adherence, consistent drug delivery, predictable bioavailability and prevention of antipsychotic overdoses. Its origins in indications such as schizophrenia and contraception, also HIV treatment and prevention.

Market Analysis and Insights: Global Long-acting Injectable Medications Market
The global Long-acting Injectable Medications market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Long-acting Injectable Medications market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Long-acting Injectable Medications market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Long-acting Injectable Medications market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Long-acting Injectable Medications market.

Global Long-acting Injectable Medications Scope and Market Size
Long-acting Injectable Medications market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Long-acting Injectable Medications market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
First-generation
Second-generation

Segment by Application
Schizophrenia
Contraception
HIV
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eli Lilly
Alkermes
Johnson & Johnson
Zogenix
DURECT
Mapi Pharma
GSK
MedinCell
Oakwood Labs
Nanomi
Pharmathen
Kashiv BioSciences

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long-acting Injectable Medications Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 First-generation
1.2.3 Second-generation
1.3 Market by Application
1.3.1 Global Long-acting Injectable Medications Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Schizophrenia
1.3.3 Contraception
1.3.4 HIV
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Long-acting Injectable Medications Market Perspective (2016-2027)
2.2 Long-acting Injectable Medications Growth Trends by Regions
2.2.1 Long-acting Injectable Medications Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Long-acting Injectable Medications Historic Market Share by Regions (2016-2021)
2.2.3 Long-acting Injectable Medications Forecasted Market Size by Regions (2022-2027)
2.3 Long-acting Injectable Medications Industry Dynamic
2.3.1 Long-acting Injectable Medications Market Trends
2.3.2 Long-acting Injectable Medications Market Drivers
2.3.3 Long-acting Injectable Medications Market Challenges
2.3.4 Long-acting Injectable Medications Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Long-acting Injectable Medications Players by Revenue
3.1.1 Global Top Long-acting Injectable Medications Players by Revenue (2016-2021)
3.1.2 Global Long-acting Injectable Medications Revenue Market Share by Players (2016-2021)
3.2 Global Long-acting Injectable Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Long-acting Injectable Medications Revenue
3.4 Global Long-acting Injectable Medications Market Concentration Ratio
3.4.1 Global Long-acting Injectable Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long-acting Injectable Medications Revenue in 2020
3.5 Long-acting Injectable Medications Key Players Head office and Area Served
3.6 Key Players Long-acting Injectable Medications Product Solution and Service
3.7 Date of Enter into Long-acting Injectable Medications Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Long-acting Injectable Medications Breakdown Data by Type
4.1 Global Long-acting Injectable Medications Historic Market Size by Type (2016-2021)
4.2 Global Long-acting Injectable Medications Forecasted Market Size by Type (2022-2027)

5 Long-acting Injectable Medications Breakdown Data by Application
5.1 Global Long-acting Injectable Medications Historic Market Size by Application (2016-2021)
5.2 Global Long-acting Injectable Medications Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Long-acting Injectable Medications Market Size (2016-2027)
6.2 North America Long-acting Injectable Medications Market Size by Type
6.2.1 North America Long-acting Injectable Medications Market Size by Type (2016-2021)
6.2.2 North America Long-acting Injectable Medications Market Size by Type (2022-2027)
6.2.3 North America Long-acting Injectable Medications Market Size by Type (2016-2027)
6.3 North America Long-acting Injectable Medications Market Size by Application
6.3.1 North America Long-acting Injectable Medications Market Size by Application (2016-2021)
6.3.2 North America Long-acting Injectable Medications Market Size by Application (2022-2027)
6.3.3 North America Long-acting Injectable Medications Market Size by Application (2016-2027)
6.4 North America Long-acting Injectable Medications Market Size by Country
6.4.1 North America Long-acting Injectable Medications Market Size by Country (2016-2021)
6.4.2 North America Long-acting Injectable Medications Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Long-acting Injectable Medications Market Size (2016-2027)
7.2 Europe Long-acting Injectable Medications Market Size by Type
7.2.1 Europe Long-acting Injectable Medications Market Size by Type (2016-2021)
7.2.2 Europe Long-acting Injectable Medications Market Size by Type (2022-2027)
7.2.3 Europe Long-acting Injectable Medications Market Size by Type (2016-2027)
7.3 Europe Long-acting Injectable Medications Market Size by Application
7.3.1 Europe Long-acting Injectable Medications Market Size by Application (2016-2021)
7.3.2 Europe Long-acting Injectable Medications Market Size by Application (2022-2027)
7.3.3 Europe Long-acting Injectable Medications Market Size by Application (2016-2027)
7.4 Europe Long-acting Injectable Medications Market Size by Country
7.4.1 Europe Long-acting Injectable Medications Market Size by Country (2016-2021)
7.4.2 Europe Long-acting Injectable Medications Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Long-acting Injectable Medications Market Size (2016-2027)
8.2 Asia-Pacific Long-acting Injectable Medications Market Size by Type
8.2.1 Asia-Pacific Long-acting Injectable Medications Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Long-acting Injectable Medications Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Long-acting Injectable Medications Market Size by Type (2016-2027)
8.3 Asia-Pacific Long-acting Injectable Medications Market Size by Application
8.3.1 Asia-Pacific Long-acting Injectable Medications Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Long-acting Injectable Medications Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Long-acting Injectable Medications Market Size by Application (2016-2027)
8.4 Asia-Pacific Long-acting Injectable Medications Market Size by Region
8.4.1 Asia-Pacific Long-acting Injectable Medications Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Long-acting Injectable Medications Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Long-acting Injectable Medications Market Size (2016-2027)
9.2 Latin America Long-acting Injectable Medications Market Size by Type
9.2.1 Latin America Long-acting Injectable Medications Market Size by Type (2016-2021)
9.2.2 Latin America Long-acting Injectable Medications Market Size by Type (2022-2027)
9.2.3 Latin America Long-acting Injectable Medications Market Size by Type (2016-2027)
9.3 Latin America Long-acting Injectable Medications Market Size by Application
9.3.1 Latin America Long-acting Injectable Medications Market Size by Application (2016-2021)
9.3.2 Latin America Long-acting Injectable Medications Market Size by Application (2022-2027)
9.3.3 Latin America Long-acting Injectable Medications Market Size by Application (2016-2027)
9.4 Latin America Long-acting Injectable Medications Market Size by Country
9.4.1 Latin America Long-acting Injectable Medications Market Size by Country (2016-2021)
9.4.2 Latin America Long-acting Injectable Medications Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Long-acting Injectable Medications Market Size (2016-2027)
10.2 Middle East & Africa Long-acting Injectable Medications Market Size by Type
10.2.1 Middle East & Africa Long-acting Injectable Medications Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Long-acting Injectable Medications Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Long-acting Injectable Medications Market Size by Type (2016-2027)
10.3 Middle East & Africa Long-acting Injectable Medications Market Size by Application
10.3.1 Middle East & Africa Long-acting Injectable Medications Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Long-acting Injectable Medications Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Long-acting Injectable Medications Market Size by Application (2016-2027)
10.4 Middle East & Africa Long-acting Injectable Medications Market Size by Country
10.4.1 Middle East & Africa Long-acting Injectable Medications Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Long-acting Injectable Medications Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Long-acting Injectable Medications Introduction
11.1.4 Eli Lilly Revenue in Long-acting Injectable Medications Business (2016-2021)
11.1.5 Eli Lilly Recent Development
11.2 Alkermes
11.2.1 Alkermes Company Details
11.2.2 Alkermes Business Overview
11.2.3 Alkermes Long-acting Injectable Medications Introduction
11.2.4 Alkermes Revenue in Long-acting Injectable Medications Business (2016-2021)
11.2.5 Alkermes Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Long-acting Injectable Medications Introduction
11.3.4 Johnson & Johnson Revenue in Long-acting Injectable Medications Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Zogenix
11.4.1 Zogenix Company Details
11.4.2 Zogenix Business Overview
11.4.3 Zogenix Long-acting Injectable Medications Introduction
11.4.4 Zogenix Revenue in Long-acting Injectable Medications Business (2016-2021)
11.4.5 Zogenix Recent Development
11.5 DURECT
11.5.1 DURECT Company Details
11.5.2 DURECT Business Overview
11.5.3 DURECT Long-acting Injectable Medications Introduction
11.5.4 DURECT Revenue in Long-acting Injectable Medications Business (2016-2021)
11.5.5 DURECT Recent Development
11.6 Mapi Pharma
11.6.1 Mapi Pharma Company Details
11.6.2 Mapi Pharma Business Overview
11.6.3 Mapi Pharma Long-acting Injectable Medications Introduction
11.6.4 Mapi Pharma Revenue in Long-acting Injectable Medications Business (2016-2021)
11.6.5 Mapi Pharma Recent Development
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Long-acting Injectable Medications Introduction
11.7.4 GSK Revenue in Long-acting Injectable Medications Business (2016-2021)
11.7.5 GSK Recent Development
11.8 MedinCell
11.8.1 MedinCell Company Details
11.8.2 MedinCell Business Overview
11.8.3 MedinCell Long-acting Injectable Medications Introduction
11.8.4 MedinCell Revenue in Long-acting Injectable Medications Business (2016-2021)
11.8.5 MedinCell Recent Development
11.9 Oakwood Labs
11.9.1 Oakwood Labs Company Details
11.9.2 Oakwood Labs Business Overview
11.9.3 Oakwood Labs Long-acting Injectable Medications Introduction
11.9.4 Oakwood Labs Revenue in Long-acting Injectable Medications Business (2016-2021)
11.9.5 Oakwood Labs Recent Development
11.10 Nanomi
11.10.1 Nanomi Company Details
11.10.2 Nanomi Business Overview
11.10.3 Nanomi Long-acting Injectable Medications Introduction
11.10.4 Nanomi Revenue in Long-acting Injectable Medications Business (2016-2021)
11.10.5 Nanomi Recent Development
11.11 Pharmathen
11.11.1 Pharmathen Company Details
11.11.2 Pharmathen Business Overview
11.11.3 Pharmathen Long-acting Injectable Medications Introduction
11.11.4 Pharmathen Revenue in Long-acting Injectable Medications Business (2016-2021)
11.11.5 Pharmathen Recent Development
11.12 Kashiv BioSciences
11.12.1 Kashiv BioSciences Company Details
11.12.2 Kashiv BioSciences Business Overview
11.12.3 Kashiv BioSciences Long-acting Injectable Medications Introduction
11.12.4 Kashiv BioSciences Revenue in Long-acting Injectable Medications Business (2016-2021)
11.12.5 Kashiv BioSciences Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Long-acting Injectable Medications Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of First-generation
Table 3. Key Players of Second-generation
Table 4. Global Long-acting Injectable Medications Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Long-acting Injectable Medications Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Long-acting Injectable Medications Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Long-acting Injectable Medications Market Share by Regions (2016-2021)
Table 8. Global Long-acting Injectable Medications Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Long-acting Injectable Medications Market Share by Regions (2022-2027)
Table 10. Long-acting Injectable Medications Market Trends
Table 11. Long-acting Injectable Medications Market Drivers
Table 12. Long-acting Injectable Medications Market Challenges
Table 13. Long-acting Injectable Medications Market Restraints
Table 14. Global Long-acting Injectable Medications Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Long-acting Injectable Medications Market Share by Players (2016-2021)
Table 16. Global Top Long-acting Injectable Medications Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long-acting Injectable Medications as of 2020)
Table 17. Ranking of Global Top Long-acting Injectable Medications Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Long-acting Injectable Medications Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Long-acting Injectable Medications Product Solution and Service
Table 21. Date of Enter into Long-acting Injectable Medications Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Long-acting Injectable Medications Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Long-acting Injectable Medications Revenue Market Share by Type (2016-2021)
Table 25. Global Long-acting Injectable Medications Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Long-acting Injectable Medications Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Long-acting Injectable Medications Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Long-acting Injectable Medications Revenue Market Share by Application (2016-2021)
Table 29. Global Long-acting Injectable Medications Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Long-acting Injectable Medications Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Long-acting Injectable Medications Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Long-acting Injectable Medications Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Long-acting Injectable Medications Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Long-acting Injectable Medications Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Long-acting Injectable Medications Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Long-acting Injectable Medications Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Long-acting Injectable Medications Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Long-acting Injectable Medications Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Long-acting Injectable Medications Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Long-acting Injectable Medications Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Long-acting Injectable Medications Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Long-acting Injectable Medications Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Long-acting Injectable Medications Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Long-acting Injectable Medications Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Long-acting Injectable Medications Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Long-acting Injectable Medications Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Long-acting Injectable Medications Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Long-acting Injectable Medications Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Long-acting Injectable Medications Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Long-acting Injectable Medications Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Long-acting Injectable Medications Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Long-acting Injectable Medications Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Long-acting Injectable Medications Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Long-acting Injectable Medications Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Long-acting Injectable Medications Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Long-acting Injectable Medications Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Long-acting Injectable Medications Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Long-acting Injectable Medications Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Long-acting Injectable Medications Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Long-acting Injectable Medications Market Size by Country (2022-2027) & (US$ Million)
Table 61. Eli Lilly Company Details
Table 62. Eli Lilly Business Overview
Table 63. Eli Lilly Long-acting Injectable Medications Product
Table 64. Eli Lilly Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million)
Table 65. Eli Lilly Recent Development
Table 66. Alkermes Company Details
Table 67. Alkermes Business Overview
Table 68. Alkermes Long-acting Injectable Medications Product
Table 69. Alkermes Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million)
Table 70. Alkermes Recent Development
Table 71. Johnson & Johnson Company Details
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Long-acting Injectable Medications Product
Table 74. Johnson & Johnson Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Zogenix Company Details
Table 77. Zogenix Business Overview
Table 78. Zogenix Long-acting Injectable Medications Product
Table 79. Zogenix Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million)
Table 80. Zogenix Recent Development
Table 81. DURECT Company Details
Table 82. DURECT Business Overview
Table 83. DURECT Long-acting Injectable Medications Product
Table 84. DURECT Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million)
Table 85. DURECT Recent Development
Table 86. Mapi Pharma Company Details
Table 87. Mapi Pharma Business Overview
Table 88. Mapi Pharma Long-acting Injectable Medications Product
Table 89. Mapi Pharma Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million)
Table 90. Mapi Pharma Recent Development
Table 91. GSK Company Details
Table 92. GSK Business Overview
Table 93. GSK Long-acting Injectable Medications Product
Table 94. GSK Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million)
Table 95. GSK Recent Development
Table 96. MedinCell Company Details
Table 97. MedinCell Business Overview
Table 98. MedinCell Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million)
Table 99. MedinCell Recent Development
Table 100. Oakwood Labs Company Details
Table 101. Oakwood Labs Business Overview
Table 102. Oakwood Labs Long-acting Injectable Medications Product
Table 103. Oakwood Labs Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million)
Table 104. Oakwood Labs Recent Development
Table 105. Nanomi Company Details
Table 106. Nanomi Business Overview
Table 107. Nanomi Long-acting Injectable Medications Product
Table 108. Nanomi Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million)
Table 109. Nanomi Recent Development
Table 110. Pharmathen Company Details
Table 111. Pharmathen Business Overview
Table 112. Pharmathen Long-acting Injectable Medications Product
Table 113. Pharmathen Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million)
Table 114. Pharmathen Recent Development
Table 115. Kashiv BioSciences Company Details
Table 116. Kashiv BioSciences Business Overview
Table 117. Kashiv BioSciences Long-acting Injectable Medications Product
Table 118. Kashiv BioSciences Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million)
Table 119. Kashiv BioSciences Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Long-acting Injectable Medications Market Share by Type: 2020 VS 2027
Figure 2. First-generation Features
Figure 3. Second-generation Features
Figure 4. Global Long-acting Injectable Medications Market Share by Application: 2020 VS 2027
Figure 5. Schizophrenia Case Studies
Figure 6. Contraception Case Studies
Figure 7. HIV Case Studies
Figure 8. Others Case Studies
Figure 9. Long-acting Injectable Medications Report Years Considered
Figure 10. Global Long-acting Injectable Medications Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Long-acting Injectable Medications Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Long-acting Injectable Medications Market Share by Regions: 2020 VS 2027
Figure 13. Global Long-acting Injectable Medications Market Share by Regions (2022-2027)
Figure 14. Global Long-acting Injectable Medications Market Share by Players in 2020
Figure 15. Global Top Long-acting Injectable Medications Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long-acting Injectable Medications as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Long-acting Injectable Medications Revenue in 2020
Figure 17. Global Long-acting Injectable Medications Revenue Market Share by Type (2016-2021)
Figure 18. Global Long-acting Injectable Medications Revenue Market Share by Type (2022-2027)
Figure 19. North America Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Long-acting Injectable Medications Market Share by Type (2016-2027)
Figure 21. North America Long-acting Injectable Medications Market Share by Application (2016-2027)
Figure 22. North America Long-acting Injectable Medications Market Share by Country (2016-2027)
Figure 23. United States Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Long-acting Injectable Medications Market Share by Type (2016-2027)
Figure 27. Europe Long-acting Injectable Medications Market Share by Application (2016-2027)
Figure 28. Europe Long-acting Injectable Medications Market Share by Country (2016-2027)
Figure 29. Germany Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Long-acting Injectable Medications Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Long-acting Injectable Medications Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Long-acting Injectable Medications Market Share by Region (2016-2027)
Figure 39. China Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Long-acting Injectable Medications Market Share by Type (2016-2027)
Figure 47. Latin America Long-acting Injectable Medications Market Share by Application (2016-2027)
Figure 48. Latin America Long-acting Injectable Medications Market Share by Country (2016-2027)
Figure 49. Mexico Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Long-acting Injectable Medications Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Long-acting Injectable Medications Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Long-acting Injectable Medications Market Share by Country (2016-2027)
Figure 55. Turkey Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Eli Lilly Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021)
Figure 59. Alkermes Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021)
Figure 61. Zogenix Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021)
Figure 62. DURECT Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021)
Figure 63. Mapi Pharma Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021)
Figure 64. GSK Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021)
Figure 65. MedinCell Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021)
Figure 66. Oakwood Labs Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021)
Figure 67. Nanomi Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021)
Figure 68. Pharmathen Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021)
Figure 69. Kashiv BioSciences Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の長時間作用型インスリン市場規模・現状・予測（2021年-2027年）

Global Long Acting Insulins Market Size, Status and Forecast 2021-2027
QFJ1-4437 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、長時間作用型インスリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（インスリングラルギン、インスリンデテミル、インスリンデグルデク、長時間作用型動物インスリン）、用途別市場規模（家庭用、医療機関、そ...

世界の速効型インスリン市場規模・現状・予測（2021年-2027年）

Global Rapid Acting Insulins Market Size, Status and Forecast 2021-2027
QFJ1-4792 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、速効型インスリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（リスプロ、アスパルト（ノボログ）、グルリジン（アピドラ））、用途別市場規模（1型糖尿病、2型糖尿病）、主要地域別市場規模（北米、アメリカ...

世界の鎮痛薬市場規模・現状・予測（2021年-2027年）

Global Pain Relief Medications Market Size, Status and Forecast 2021-2027
QFJ1-5924 2021年6月 118Pages
QYResearch社発行の本調査レポートでは、鎮痛薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ジェネリックオピオイド、ブランドオピオイド、NSAID、その他）、用途別市場規模（病院、クリニック、ドラッグストア）、主要地域別市場規模（北米、ア...

世界の禁煙用医薬品市場規模・現状・予測（2021年-2027年）

Global Medications for Smoking Cessation Market Size, Status and Forecast 2021-2027
QFJ1-5847 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、禁煙用医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ニコチン薬、ニコチン置換療法（NRT））、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の注射式標的治療市場規模・現状・予測（2021年-2027年）

Global Injectable Targeted Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4374 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、注射式標的治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、小分子、免疫毒素、その他）、用途別市場規模（病院、在宅医療、専門クリニック、その他）、主要地域別市場規模（北米、アメリ...

世界の注射式鎮痛薬市場規模・現状・予測（2021年-2027年）

Global Injectable Pain Medication Market Size, Status and Forecast 2021-2027
QFJ1-4373 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、注射式鎮痛薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ステロイド性抗炎症薬（NSAID）、中枢作用性鎮痛薬）、用途別市場規模（病院、クリニック、リカバリーセンター）、主要地域別市場規模（北米、...

世界の注射式駆虫薬市場規模・現状・予測（2021年-2027年）

Global Injectable Anthelmintic Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4371 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、注射式駆虫薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ベンズイミダゾール、ピペラジン、イミダゾチアゾール、スピロインドール、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、動物用薬...

世界の注射式骨代替物市場規模・現状・予測（2021年-2027年）

Global Injectable Bone Substitute Market Size, Status and Forecast 2021-2027
QFJ1-5213 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、注射式骨代替物の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（天然、合成）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、...

世界の注射式しわ治療市場規模・現状・予測（2021年-2027年）

Global Injectable Anti-Wrinkle Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4372 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、注射式しわ治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（筋弛緩薬、ヒアルロン酸リンクルフィラー、合成リンクルフィラー、コラーゲンリンクルフィラー、自己リンクルフィラー）、用途別市場規模（男性用、...

世界の高分子注射薬市場規模・現状・予測（2021年-2027年）

Global Large Molecule Injectable Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4411 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、高分子注射薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（静脈注射、筋肉注射、皮下注射）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の長時間作用型インスリン市場規模・現状・予測（2021年-2027年） Long Acting Insulins (are also called basal or background insulins) can control blood sugar for an entire day. Bovine PZI (protamine zinc insulin), can last anywhere up to 36 hours. Long acting insulins are available in animal and analogue forms. They can be used for a number of different types of d…
世界の速効型インスリン市場規模・現状・予測（2021年-2027年） Rapid Acting Insulins are usually taken before or with a meal. They act very quickly to minimise the rise in blood sugar which follows eating. Rapid acting insulins can be used for both type 1 and type 2 diabetes, injected or delivered via an insulin pump. Market Analysis and Insights: Global Rapid …
世界の急速充電市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Quick-acting Charging Market The global Quick-acting Charging market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report…
世界の注射式標的治療市場規模・現状・予測（2021年-2027年） It is at the cellular and molecular level, designed for the treatment of well-defined carcinogenic sites, and designing corresponding therapeutic drugs. When drugs enter the body, they will specifically select carcinogenic sites to combine and act, causing tumor cells to die specifically, without Wi…
世界の注射式鎮痛薬市場規模・現状・予測（2021年-2027年） Analgesics refer to drugs that can partially or completely relieve pain. There are two types of non-steroidal anti-inflammatory drugs and central analgesics. The latter is currently mainly used in the treatment of cancer pain, and can also be used for short-term postoperative pain relief. Market Ana…